Skip to main content

Advertisement

Table 1 Baseline characteristics in patients and controls

From: Overweight and obesity impair left ventricular systolic function as measured by left ventricular ejection fraction and global longitudinal strain

  Patients n = 384 Controls n = 184 p
Demographic data
 Age, years 61 (5) 64 (9) < 0.001
 Female, n (%) 113 (29) 91 (49) < 0.001
 Smoker or former smoker, n (%) 257 (67) 91 (49) < 0.001
 Height, cm 174 (12) 172 (14) ns
 Weight, kg 90 (19) 76 (21) < 0.001
 BMI, kg/m2 30 (6) 26 (5) < 0.001
Medical history
 Diabetes duration, years 6 (7) 0 na
 Angina pectoris, n (%) 30 (8) 3 (2) < 0.01
 Myocardial infarction, n (%) 24 (6) 5 (3) ns
 Coronary revascularization, n (%) 25 (6) 4 (2) < 0.05
 Heart failure, n (%) 8 (2) 0 na
 Hypertension, n (%) 253 (66) 43 (23) < 0.001
Medication
 Loop diuretics, n (%) 26 (7) 0 na
 Statins, n (%) 230 (60) 19 (10) < 0.001
 ACEI and/or ARB, n (%) 187 (49) 21 (11) < 0.001
 Calcium channel blocker, n (%) 68 (18) 9 (6) < 0.001
 β-Blocker, n (%) 138 (36) 25 (14) < 0.001
Laboratory analyses
 HbA1c, % 5.8 (1.3)   na
 Triglycerides, mmol/L 1.5 (1.0) 1.1 (0.8) < 0.001
 Triglycerides, mg/dL 133 (88) 97 (71) < 0.001
 LDL-C, mmol/L 2.5 (0.9) 3.5 (1.0) < 0.001
 LDL-C, mg/dL 96 (35) 135 (39) < 0.001
 Microalbuminuria, n (%) 60 (16) 7 (4) < 0.001
 Creatinine, µmol/L 88 (23) 77 (20) < 0.001
 Creatinine, mg/dL 1.00 (0.26) 0.87 (0.23) < 0.001
 GFR, mL/min/1.73 m2 70 (20) 76 (18) < 0.001
Blood pressure (mmHg)
 Systolic blood pressure 137 (20) 128 (30) < 0.001
 Diastolic blood pressure 78 (12) 74 (15) < 0.001
  1. Values are presented as numbers of participants and percent for categorical variables, and median and (interquartile range) for continuous variables
  2. ns not significant, na not applicable, BMI body mass index, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker, HbA1c glycosylated haemoglobin, LDL-C low-density lipoprotein cholesterol